Grindeks Kalceks Eesti OÜ

Active Registry code 16484359 OÜ Tallinn Registered 20 Apr 2022
Compare

Grindeks Kalceks Eesti OÜ is a OÜ based in Tallinn, registry code 16484359, status: active. Main activity: Wholesale of medicines and other pharmacy goods. Its annual report for 2023 shows revenue of €0 and 1 employees.

Turnover
—
State taxes
1 590 €
↓ 61.4% vs Q3 2023
Labour taxes
1 614 €
↓ 61.4% vs Q3 2023
Employees
—

Q4 2023 · data from the Tax and Customs Board (EMTA)

Position in the industry Wholesale trade · EMTAK 46

  • Revenue · 2023 0 €
    industry median 63 715 € · companies in the industry: 10 708

Taxes and turnover

Q2 2023 – Q4 2023
Employees Q2 2023: 1
0.00.20.40.60.81.0Q2 2023 Company: 1Q2·23Q3 2023 Company: —Q3·23Q4 2023 Company: —Q4·230.00.20.40.60.81.0Q2 2023 Company: 1Q2·23Q3 2023 Company: —Q4 2023 Company: —Q4·23
State taxes, € Q4 2023: 1 590 € · −61.4% vs Q3 2023
01 0002 0003 0004 0005 000Q2 2023 Company: —Q2·23Q3 2023 Company: 4 120 €Q3·23Q4 2023 Company: 1 590 €Q4·2301 0002 0003 0004 0005 000Q2 2023 Company: —Q2·23Q3 2023 Company: 4 120 €Q4 2023 Company: 1 590 €Q4·23
Figures by quarter
Quarter Turnover, € State taxes, € Labour taxes, € Employees
Q4 2023 — 1 590 1 614 —
Q3 2023 — 4 120 4 182 —
Q2 2023 — — — 1

Financials by year

2022 – 2025
Revenue, € 2023: 0 € · industry median 63 715 € · above 5% of the industry
020 00040 00060 00080 0002022 Company: 0 € Industry median: 75 397 €20222023 Company: 0 € Industry median: 63 715 €20232024 Company: — Industry median: 60 216 €20242025 Company: — Industry median: 63 691 €2025020 00040 00060 00080 0002022 Company: 0 € Industry median: 75 397 €2023 Company: 0 € Industry median: 63 715 €20232024 Company: — Industry median: 60 216 €2025 Company: — Industry median: 63 691 €2025
  • Company
  • Industry median

Industry: Wholesale trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: 12 498 € · +3 591.1% vs 2024 · industry median 127 € · above 72% of the industry
-20 000-10 000010 00020 0002022 Company: 0 € Industry median: 889 €20222023 Company: -14 604 € Industry median: 370 €20232024 Company: -358 € Industry median: 134 €20242025 Company: 12 498 € Industry median: 127 €2025-20 000-10 000010 00020 0002022 Company: 0 € Industry median: 889 €2023 Company: -14 604 € Industry median: 370 €20232024 Company: -358 € Industry median: 134 €2025 Company: 12 498 € Industry median: 127 €2025
  • Company
  • Industry median

Industry: Wholesale trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2025: 36 € · +500.0% vs 2024
05001 0001 5002 0002 5002022 Company: 2 500 €20222023 Company: 6 €20232024 Company: 6 €20242025 Company: 36 €202505001 0001 5002 0002 5002022 Company: 2 500 €2023 Company: 6 €20232024 Company: 6 €2025 Company: 36 €2025
Equity, € 2025: 36 € · +100.3% vs 2024
-15 000-10 000-5 00005 0002022 Company: 2 500 €20222023 Company: -12 104 €20232024 Company: -12 462 €20242025 Company: 36 €2025-15 000-10 000-5 00005 0002022 Company: 2 500 €2023 Company: -12 104 €20232024 Company: -12 462 €2025 Company: 36 €2025
Employees 2025: 0 · industry median 2 · above 2% of the industry
0.00.51.01.52.02022 Company: 0 Industry median: 220222023 Company: 1 Industry median: 220232024 Company: 0 Industry median: 220242025 Company: 0 Industry median: 220250.00.51.01.52.02022 Company: 0 Industry median: 22023 Company: 1 Industry median: 220232024 Company: 0 Industry median: 22025 Company: 0 Industry median: 22025
  • Company
  • Industry median

Industry: Wholesale trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 — 12 498 0 36 36 0
2024 — -358 0 6 -12 462 0
2023 0 -14 604 14 414 6 -12 104 1
2022 0 0 0 2 500 2 500 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Return on equity (ROE)
34 716.7 %
Net profit / equity
Return on assets (ROA)
34 716.7 %
Net profit / assets
Equity ratio
100.0 %
Equity / assets
Debt ratio
0.0 %
Liabilities / assets

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 31 Jul 2026 Company’s own e-Äriregister
2024 1 Jan 2024 – 31 Dec 2024 30 Jun 2025 Company’s own e-Äriregister
2023 1 Jan 2023 – 31 Dec 2023 30 Jun 2024 Company’s own e-Äriregister
2022 20 Apr 2022 – 31 Dec 2022 27 Jun 2023 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Any procurator may represent the private limited company in all legal acts related to its business. A procurator may transfer or encumber immovable property only if that right is entered on the registry card.

Owners

  • Akciju sabiedrība GRINDEKS
    Legal person · 2 500 €

Beneficial owners

No beneficial owners listed.

Founders and other persons

  • Akciju sabiedrība GRINDEKS
    Founder · 2 500 € · 5 Apr 2022
shared board members, owners or beneficial owners

Activities (EMTAK)

  • 46461Wholesale of medicines and other pharmacy goods Main
Rulings
Number, date Title Deadline State Document
Ä 50201128 / M4
12 Oct 2026
Ruling to eliminate deficiencies 17 Nov 2026 Signed
12 Oct 2026
PDF
Ä 50201128 / M3
3 Aug 2026
Warning of compulsory dissolution: insufficient net assets 3 Feb 2027 In force
3 Aug 2026
PDF
Ä 50201128 / 5
24 Jul 2026
Amendment entry In force
24 Jul 2026
PDF
Ä 50201128 / M2
1 Jul 2026
Ruling to eliminate deficiencies 31 Jul 2026 Deficiencies eliminated
24 Jul 2026
PDF
Ä 50201128 / 4
1 Sep 2023
Amendment entry In force
1 Sep 2023
PDF
Ä 50201128 / 3
3 May 2023
Amendment entry In force
3 May 2023
PDF
Ä 50201128 / M1
10 Mar 2023
Procedural ruling In force
10 Mar 2023
PDF
Ä 50201128 / 2
9 May 2022
Amendment entry In force
9 May 2022
PDF
Ä 50201128
20 Apr 2022
First entry In force
20 Apr 2022
PDF

Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data